XML 131 R103.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Financial Instruments were Denominated in U S Dollars (Detail)
$ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
CAD ($)
Dec. 31, 2022
CAD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Disclosure of detailed information about financial instruments [Line Items]        
Cash $ 54,182 $ 21,587    
Accounts receivable 421,427 413,925    
Accounts payable and accrued liabilities (342,382) (392,053)    
Canadian Operations [Member] | Currency Risk [Member]        
Disclosure of detailed information about financial instruments [Line Items]        
Cash     $ 9,539 $ 264
Accounts receivable     17 215
Accounts payable and accrued liabilities     (26,706) (28,041)
Long-term liabilities, excluding long-term incentive plans [1]     0 0
Net foreign currency exposure     (17,150) (27,562)
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on net earnings (loss) (172) (276)    
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on comprehensive loss 0 0    
Foreign Operations [Member] | Currency Risk [Member]        
Disclosure of detailed information about financial instruments [Line Items]        
Cash     16,459 13,421
Accounts receivable     148,885 175,543
Accounts payable and accrued liabilities     (120,416) (101,531)
Long-term liabilities, excluding long-term incentive plans [1]     (13,708) (14,542)
Net foreign currency exposure     $ 31,220 $ 72,891
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on net earnings (loss) 0 0    
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on comprehensive loss $ 312 $ 729    
[1] Excludes U.S. dollar long-term debt that has been designated as a hedge of the Corporation’s net investment in certain self-sustaining foreign operations.